to control Th2-skewing cultures (Fig.1D) . Interestingly, the concentration of IFN-γ 71 was lower when rShh was added compared to control Th1 cultures (Fig.1E ). After 7 72 days of culture and CD3/CD28 restimulation, the proportion of CD4 T-cells that 73 expressed IL-4 was significantly increased in the presence of rShh under Th2 74 conditions (Fig. 1F) . In contrast, the percentage of cells that expressed IFN-γ was 75 reduced in Th1+rShh cultures compared to Th1 cells (Fig. 1G) . Shh-treatment 76 increased GATA3 and IL4 expression in Th2 cultures (Fig.1H) , whereas rShh-77 treatment decreased IFNG and TBX21 (TBET) expression in Th1 cultures (Fig.1I) . 78
These data indicate that Hh signalling promotes Th2 differentiation in human CD4 T-79 cells, with simultaneous repression of IFN-γ and ΤΒΕΤ. 80
We then investigated whether pharmacological inhibition of the Hh signalling 81 pathway, by treatment with an inhibitor of the non-redundant Hh-signal transduction 82 molecule SMO (PF-04449913) would impair Th2 differentiation(6). The proportion 83 of cells that expressed the Th1 lineage-specific transcription factor TBET was not 84 affected by SMO-inhibitor treatment under skewing conditions ( Fig.2A) . Likewise, 85 no differences were found in the expression of GATA3 under neutral or Th1 86 conditions (Fig.2B) . However, SMO-inhibitor-treatment significantly reduced the 87 proportion of CD4 T-cells that expressed GATA3 and KI67 (marker of proliferation) 88 when cultured under Th2 skewing conditions (Fig.2B-C showed that IFN-γ levels were similar in both groups under Th1 conditions (Fig. 2F) , 95 but under Th2 conditions significantly lower concentrations of IL-4 were found in the 96 SMO-inhibitor group compared to controls (Fig. 2G) . Finally, we investigated the 97 transcript levels of IL4 and IFNG by QRT-PCR. In Th2 skewed cells IL4 expression 98 was significantly lower in SMO-inhibitor-treated cultures than controls (Fig. 2H) , 99
whereas IFNG transcript levels were not different between groups under Th1 100 conditions ( 
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In humans, GWAS linked components of the Hedgehog (Hh) signalling pathway to 119 allergic asthma (8), and a recent study found that children with asthma presented with 120 higher levels of SHH in airway epithelia than healthy controls (9). 121
Here we provide in vitro evidence that Hedgehog signalling enhances Th2 122 differentiation in human CD4 T-cells. One strength of our study is that our 123 experiments were performed using cells isolated from 12 different unknown leucocyte 124 cone donors, and we obtained consistent experimental results from all donors, 125 independent of their age or gender (of which we had no knowledge). A weakness of 126 our study is that it was limited to in vitro experimentation. In the future it will 127 therefore be interesting to assess the Th differentiation status of T-cell populations 128 

Material and Methods
Human naïve CD4 purification and culture
Human peripheral blood mononuclear cells (PBMCs) were freshly isolated from randomly-selected unknown leucocyte-cone donors (UK NHS Blood and Transplant Centre) by gradient centrifugation using Lymphoprep (Axis-Shield; Olso, Norway).
The donors to the UK NHS Blood and Transplant Centre are aged between 17 and 65 years old and we had no knowledge of their age, gender or identity. Ethical approved was authorized by local area NHS REC (research ethics committee). Naïve CD4 T-
were magnetic-bead purified from PBMC using EasySep Isolation Kit (StemCell). Purity of naïve CD4 T-cells was analysed by flow cytometry and exceeded 95%. After magnetic-bead isolation, naive CD4 T-cells were rested for 3-5 hours and then plated in 96 round well plates at 1x10 6 cells/ml.
Cells were stimulated in complete RPMI (supplemented with 10%FBS, 1% penicilinstreptomycin and 10 -5 M 2-mercaptoethanol) with 5µg/ml plate-bound anti-CD3
antibody (clone UCHT1) and anti-CD28 antibody (eBioscience). For Th0 conditions no cytokines were added; For Th1: anti-IL-4 (5µg/ml), rIL-12 (20ng/ml), rIFN-γ (10ng/ml); and for Th2: anti-IFNγ (2.5µg/ml), rIL-4 (20ng/ml) were added. After 4 days, cells were expanded in human rIL-2 (100U/mL) for 3 days in fresh medium containing the same skewing cytokines and neutralising antibodies but in the absence of anti-CD3 and CD28 stimulation. Cells were then restimulated for 16 hours by addition of soluble anti-CD3 and anti-CD28 (1µg/ml) prior to gene expression and cytokine analysis. Where stated, recombinant Shh (rShh) (R&D Systems) was added at a final concentration of 0.5µg/ml at the initiation of culture, and again on day 4
when the medium was changed and the cells expanded by addition of rIL2.
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Where stated, SMO-inhibitor (PF-04449913; Pfizer, dissolved in DMSO) was added to cultures for a final concentration of 1nM/ml; (1µl/ml) and an equivalent volume/concentration of DMSO alone was added to control wells (DMSO at 1:10,000 final dilution). This treatment or control was added to the corresponding wells every day until the end of the experiment.
For intracellular (ic) cytokine staining, CD4 T-cells were stimulated for 4 h with 50 ng/ml PMA (Sigma-Aldrich), 500ng/ml ionomycin (Sigma-Aldrich), and 3µg/ml Brefeldin A (eBioscience).
Flow cytometry
Cells were stained using combinations of directly conjugated antibodies from 
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Quantitative (Q)RT-PCR
RNA was extracted using PicoPure kit (Applied Biosystems). cDNA was synthesized using High Capacity cDNA reverse transcription kit (Applied Biosystems) and were analysed on an iCycler (Bio-Rad Laboratories, Hercules, CA) using SYBR Green Supermix (Bio-Rad) following manufacturer's guidelines. RNA levels obtained from each sample were measured relative to the housekeeping gene HPRT. All primers were purchased from Qiagen.
Statistical analysis
Paired two-tailed student's t test was used for statistical analysis for comparison of in vitro treatments of cells from a given individual. Probabilities were considered significant if p < 0.05(*), p < 0.01(**), and p < 0.001(***).
